| Date Filed | Type | Description |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 02/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 11/19/2020 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Unknown transaction of 4,100 shares
@ $0
Disposed/sold 22,000 options to buy
@ $7.4, valued at
$162.8k
Disposed/sold 11,000 options to buy
@ $13.6, valued at
$149.6k
Disposed/sold 11,000 options to buy
@ $14, valued at
$154k
Disposed/sold 11,000 options to buy
@ $48.85, valued at
$537.4k
Disposed/sold 6,600 options to buy
@ $47.77, valued at
$315.3k
Disposed/sold 3,000 options to buy
@ $100.27, valued at
$300.8k
|
|
| 06/23/2020 |
4/A
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/22/2020 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Granted 3,000 options to buy
@ $100.27, valued at
$300.8k
Granted 1,800 restricted stock units
@ $0 |
|
| 06/16/2020 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia, Inc.|
Txns:
| Exercised 2,300 restricted stock units
@ $0 |
|
| 06/11/2020 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 20,000 options to buy
@ $5.25, valued at
$105k
|
|
| 06/17/2019 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 6,600 options to buy
@ $47.17, valued at
$311.3k
Granted 2,300 restricted stock units
@ $0 |
|
| 06/03/2019 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.42, valued at
$59.6k
|
|
| 06/14/2018 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 11,000 options to buy
@ $48.85, valued at
$537.4k
|
|
| 06/04/2018 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $5.15, valued at
$56.7k
|
|
| 03/07/2018 |
4
| AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Disposed/sold 84,549 shares
@ $0
Disposed/sold 29,135 shares
@ $0
Disposed/sold 35,893 shares
@ $0
Disposed/sold 313,797 options to buy
@ $24.01, valued at
$7.5M
|
|
| 02/02/2018 |
4
| AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 29,135 shares
@ $0 |
|
| 10/20/2017 |
4
| AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 35,893 shares
@ $0 |
|
| 10/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2017 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 11,000 options to buy
@ $14, valued at
$154k
|
|
| 06/13/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 04/17/2017 |
4
| AGARWAL SUNIL (President of R & D) has filed a Form 4 on Juno Therapeutics, Inc.|
Txns:
| Granted 96,627 shares
@ $0
Paid exercise price by delivering 4,793 shares
@ $24.01, valued at
$115.1k
Granted 313,797 options to buy
@ $24.01, valued at
$7.5M
|
|
| 04/17/2017 |
3
| AGARWAL SUNIL (President of R & D) has filed a Form 3 on Juno Therapeutics, Inc. |
| 08/23/2016 |
4
| AGARWAL SUNIL (Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 392 shares
@ $66, valued at
$25.9k
|
|
| 07/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2016 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on Calithera Biosciences, Inc.|
Txns:
| Granted 11,000 options to buy
@ $4.76, valued at
$52.4k
|
|
| 06/09/2016 |
4
| AGARWAL SUNIL (Director) has filed a Form 4 on MyoKardia Inc|
Txns:
| Granted 11,000 options to buy
@ $13.6, valued at
$149.6k
|
|
| 05/26/2016 |
4
| AGARWAL SUNIL (Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 650 shares
@ $66, valued at
$42.9k
|
|
| 05/23/2016 |
4
| AGARWAL SUNIL (Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 392 shares
@ $61.46, valued at
$24.1k
Paid exercise price by delivering 414 shares
@ $64.01, valued at
$26.5k
|
|
| 04/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/24/2016 |
4
| AGARWAL SUNIL (Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 650 shares
@ $61.45, valued at
$39.9k
|
|
| 03/22/2016 |
4
| AGARWAL SUNIL (Chief Medical Officer) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Paid exercise price by delivering 392 shares
@ $56.32, valued at
$22.1k
|
|
|